Promoter collection, Human E2F1 promoter
Alternative name | U3022-2 |
---|---|
Clone info. | PCR amplified human E2F1 promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 33687850 to 33686378(NC_000020.11); relatively -1465 to +8, where +1 corresponds to 1 nt of NM_005225.3. |
Comment | PCR cloning, forward primer :aaggggacatggcattgtta; reverse primer : aaagtcccggccacttttac. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human E2F transcription factor 1 genomic DNA |
Depositor|Developer | DNA Bank, | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07810 | pGL4-phE2F1 | DNA solution |
Materials & Methods section:
The pGL4-phE2F1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07810). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07810_A4Hb.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: pGL4-4174F Sequence file: RDB07810_A4Hba.seq |
---|
>07810_07810_A4Hb_pGL4-4174F_E07_13.ab1 1 AATTGTGTCC AGAAATTTCT CTGGCCTAAC TGGCCGGTAC CTGAGCTCGC TAGCCTCGAG 61 GATAAGGGGA CATGGCATTG TTAAAATGCA GATTCTTGGG CACCTAGAGA TTTTAAATTG 121 GCAGGGCCAG GGTGGGCCCA AAATTAGCAA GTGACCACGT GGTTCTGAAG CCAGTGGCCT 181 AAGGACCACC CTTGCAGAAC CGTGGTCTCC TTGTCACAGT CTAGGCAGCC TCTGGCTTAG 241 CCTCTGTTTC TTTCATAACC TTTCTCAGCG CCTGCTCTGG GCCAGACCAG TGTTGGGAGG 301 AGTCGCTACT GAGCTCCTAG ATTGGCAGGG GAGGCAGATG GAGAAAAGGA GTGTGTGTGG 361 TCAGCATTGG AGCAGAGGCA GCAGTGGGCA ATAGAGGAAG TGAGTAAATC CTTGGGAGGG 421 CTCCCTAGAA GTGATGTGTT TTCTTTTTTT GTTTTAGAGA CAGGATCTCG CTCTGTCGCC 481 CAGGCTGGTG TGCAGTGGCA TGATCATAGC TCACTGCAGC CTCGACTTCT CGGGCTCAAG 541 CAATCCTCCC ACCTCAGCCT CCCAAGTAGC TGGGACTACG GGCACACGCC ACCATGCCTG 601 GCTAATTTTT GTATTTTTTG TAGAGATGGG TCTTCACCAT GTTGATCAGG CTGGTCTCGA 661 ACTCCTGGGC TCATGCGATC CACCCCGCCA GCTGATTACA GGGATTCCGG TGGTGAGCCA 721 CCGCGCCCAG ACGCCACTTC ATCGTATTGT AAACGTCTGT TACCTTTCTG TTCCCCTGTC 781 TACTGGACTG TGAGCTCCTT AGGGCCACGA ATTGAGGATG GGGCACAGAG CAAGCTCTCC 841 AAACGTTTGT TGAATGAGTG AGGGAATGAA TGAGTTCAAG CAGATGCTAT ACGTTGGCTG 901 TTGGAGATTT TGGCTAAAAT GGGACTTGCA GGAAAGCCCG ACGTCCCCCT CGCCATTTCC 961 AGGCACCGCT CTTCAGCTTG GGCTCTGGGT GAGCGGGATA GGGCTGGGTG CAGGATTAGG 1021 ATAATGTCAT GGGTGAGCAA GTTGGAGGAT GAGAGTGGCT GATGCTGGCT GTGTACTGAT 1081 GATCTTGAAA GAGAGGACAG TCTCTGGCAA TCTTAAGCCT TGAAGGCCTT GT // |
Primer: pGL4-136R Sequence file: RDB07810_A4Hbb.seq |
>07810_07810_A4Hb_pGL4-136R_F07_16.ab1 1 GTCTCTTTGT TTTTTGGCAT CTTCATGGTG GCTTTACCAA CAGTACCGCG CATTGCCAAG 61 CTTGGCCGCC GAGGCCAGAT CTTGATAAAG TCCCGGCCAC TTTTACGCGC CAAATCCTTT 121 TTGCCGCGAA AGAGCCACGA GCCGCCGAGC GCCGCCACAA TTGGCTGCCC CGGCCGTGAC 181 GGGAACAACG GCGGCGGTTC CTATTGGCTT TAACGCGCCG GACCCGGCGG CGAGGGGCGG 241 GATGGGGCGG CGGCGCGGGG CGGTACGGCC AATGGCGGGG CGGGGCGCGC GCAGGCTTTG 301 TCCGGATGGT ACCAGGCGCG GTCTGACTCC CCGCCCCCAG CCCGGGCGTC CCCTGCTGGA 361 GGCGTGGGGA CACGGGAACA TAGGCCCCGC CCCGCCCCGA CGCTCCCGCA TCCCACTGAC 421 CTTTCTATAG TGCAGGTTCA GAACAGAGCC TCTCTTCTGC ACGTGACCCT CAACCTGTAG 481 CCCCCAACAG CCTCAGCTTA GATTTCCAGA GACTGTCCCC TCTTCTTTTC AGGATCATCA 541 GTTCCACAGC CCAGCCATCA GCCACCTCTT CCATCCTCAA CTTGCCTCAC CCATGACATT 601 ATCCTAATCC TGCACCCAGC CCTATCCCGC TCACCCAGAG CCCAAGCTGA AGAGCGGTGC 661 CTGGAAATGG CGAGGGGGAC GTCGGGCTTT CCTGCAAGTC CCATTTTAGC CAAAATCTCC 721 AACAGCCAAC GTATAGCATC TGCTTGAACT CATTCATTCC CTCACTCATT CAACAAACGT 781 TTGGAGAGCT TGCTCTGTGC CCCATCCTCA ATTCGTGGCC CTAAGGAGCT CACAGTCCAG 841 TAGACAGGGG AACAGAAAGG TAACAGACGT TTACAATACG ATGAAGTGGC GTCTGGGCGC 901 GGTGGCTCAC CACCGGAATC CCTGTAATCA GCTGGCGGGG TGGATCGCAT GAGCCCAGGA 961 GTTCGAGACC AGCCCTGATC AACATGGTGA AAGACCCCAT CTCTACAAAA AATACCAAAA 1021 AATTTAGCCA GGCATGGTTG GCGTGTGCCC GTAGTCCCAG CTACTTGGGA AGCCTGAGTG 1081 GGAAGGATTG GCGTGGAGCT CTGAGAAGGT TCGAGCCTGG CAGTTGAGCC TTAATGTGAA 1141 TCTCA // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content